OICHARTS
8 AMThe 8 AM report →
PharmaMedium impactPre-market

Divi's Laboratories Q4 net profit rises 13% YoY

pre-market1 source ↓written by the desknot a recommendation

from ₹662 cr
13% YoY growth
compared to ₹2
10% to ₹2,831 cr

Divi's Laboratories reported a consolidated net profit of ₹751 cr, marking a 13% YoY growth from ₹662 cr. Revenue from operations increased 10% to ₹2,831 cr compared to ₹2,585 cr last year. The company also announced a final dividend of ₹30 per share for FY26, pending AGM approval.

Not investment advice. For informational purposes only.

OI Charts is not a SEBI-registered investment adviser or research analyst. This bulletin was written by the OI Charts desk from the public sources listed here. It is commentary on market conditions, not a basis for any investment decision and not a recommendation to buy or sell any security. Prices as of 24 May 2026, 07:03 IST.

Sourcesnews.google.com

Thread · DIVISLABSAll DIVISLABS bulletins →

Related